Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03212976 · ClinicalTrials.gov registry record · NA

Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure

A NA study, sponsored by University of Miami.

Terminated
Registry status
NA
Development phase
11
Enrollment target

NCT03212976: Clinical Trial NA study, sponsored by University of Miami.

NCT03212976 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03212976, a NA study, was terminated before completion, sponsored by University of Miami.

TERMINATED
Registry status
NA
Development phase
11 participants
Enrollment target

Study Summary

This study is designed to evaluate the accuracy of a non-invasive method phase-contrast magnetic resonance imaging (MR-ICP) for assessing intracranial pressure (Phase 1). To perform second phase contrast imaging to evaluate the patency and flow of ventricular catheters after MR-ICP imaging (Phase 2).

Primary Outcome

Ratio of intracranial volume

Interventions

  • PROCEDURE Phase contrast magnetic resonance imaging

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2017-10-26
Est. Completion 2020-10-15
Phase NA
University of Miami

721 total trials

Why NCT03212976 stopped before completion

NCT03212976 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Phase contrast magnetic resonance imaging is the first listed.

NCT03212976 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03212976 about?

NCT03212976 is a clinical study titled "Clinical Efficacy of a Non-Invasive Measure of Intracranial Pressure". This study is designed to evaluate the accuracy of a non-invasive method phase-contrast magnetic resonance imaging (MR-ICP) for assessing intracranial pressure (Phase 1). To perform second phase contrast imaging to evaluate the patency and flow of ventricular catheters after MR-ICP imaging (Phase 2...

What is the current status of trial NCT03212976?

This trial is currently terminated. It is a NA study. The enrollment target is 11 participants. The study started on 2017-10-26. Estimated completion is 2020-10-15.

What interventions are being tested in trial NCT03212976?

The interventions under investigation include: Phase contrast magnetic resonance imaging (PROCEDURE).

Who is sponsoring clinical trial NCT03212976?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03212976's enrollment target sits among peer trials

11 1927th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03114462 · 11 participants · Phase 1

    Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

  • NCT06039709 · 11 participants · Phase 1

    Sonodynamic Therapy in Patients With Recurrent GBM

  • NCT06425380 · 11 participants · NA

    Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy

  • NCT06472661 · 11 participants · Early Phase 1

    FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03212976, the US trial registry maintained by the National Library of Medicine. NCT03212976 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.